These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7974675)
21. HIV-1 infection as a risk factor for leprosy; a case-control study in Tanzania. Borgdorff MW; van den Broek J; Chum HJ; Klokke AH; Graf P; Barongo LR; Newell JN Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):556-62. PubMed ID: 8151186 [TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus and leprosy--type 1 reactions, nerve damage and steroid therapy: 'a case report'. Bwire R; Kawuma HJ Lepr Rev; 1993 Sep; 64(3):267-9. PubMed ID: 8231607 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation. Batungwanayo J; Taelman H; Dhote R; Bogaerts J; Allen S; Van de Perre P Am Rev Respir Dis; 1992 Jul; 146(1):53-6. PubMed ID: 1626814 [TBL] [Abstract][Full Text] [Related]
24. CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases (leprosy, tuberculosis), HIV infections, and normal healthy adults: a comparative analysis of studies in different regions of India. Hussain T; Kulshreshtha KK; Yadav VS; Katoch K J Immunoassay Immunochem; 2015; 36(4):420-43. PubMed ID: 25350657 [TBL] [Abstract][Full Text] [Related]
25. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435 [TBL] [Abstract][Full Text] [Related]
26. Asymmetric Nerve Enlargement: A Characteristic of Leprosy Neuropathy Demonstrated by Ultrasonography. Lugão HB; Nogueira-Barbosa MH; Marques W; Foss NT; Frade MA PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004276. PubMed ID: 26646143 [TBL] [Abstract][Full Text] [Related]
27. Viral Co-infection and Leprosy Outcomes: A Cohort Study. Machado PR; Machado LM; Shibuya M; Rego J; Johnson WD; Glesby MJ PLoS Negl Trop Dis; 2015; 9(8):e0003865. PubMed ID: 26267882 [TBL] [Abstract][Full Text] [Related]
28. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072 [TBL] [Abstract][Full Text] [Related]
29. The effect of HIV status on the clinical picture of leprosy: a prospective study in Ethiopia. Gebre S; Saunderson P; Messele T; Byass P Lepr Rev; 2000 Sep; 71(3):338-43. PubMed ID: 11105493 [TBL] [Abstract][Full Text] [Related]
30. Selective loss of Mycobacterium leprae responsiveness of circulating lymphocytes in primary neuritic leprosy. Nath I; Narayanan RB; Sathish M; Ahuja GK; Bhutani LK; Singh R Lepr Rev; 1981 Mar; 52(1):79-89. PubMed ID: 7017320 [No Abstract] [Full Text] [Related]
31. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. Kashala O; Marlink R; Ilunga M; Diese M; Gormus B; Xu K; Mukeba P; Kasongo K; Essex M J Infect Dis; 1994 Feb; 169(2):296-304. PubMed ID: 7906291 [TBL] [Abstract][Full Text] [Related]
32. AIDS and tuberculosis/leprosy in Nigeria: the urbanisation factor. Awofeso N Acta Leprol; 1995; 9(3):149-51. PubMed ID: 7631586 [TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus- 1 in leprosy patients attending Kenyatta National Hospital, Nairobi. Munyao TM; Bwayo JJ; Owili DM; Ndinya-Achola JO; Kwasa TO; Kreiss JK East Afr Med J; 1994 Aug; 71(8):490-2. PubMed ID: 7867537 [TBL] [Abstract][Full Text] [Related]
34. Comparative brain pathology of HIV-seronegative and HIV-infected drug addicts. Makrigeorgi-Butera M; Hagel C; Laas R; Puschel K; Stavrou D Clin Neuropathol; 1996; 15(6):324-9. PubMed ID: 8937778 [TBL] [Abstract][Full Text] [Related]
35. Monitoring steroid use in a field program; possible process indicators. Saunderson PR; Haile-Mariam N Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):217-23. PubMed ID: 9251594 [TBL] [Abstract][Full Text] [Related]
36. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions. Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172 [TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus and leprosy: an update. Lockwood DN; Lambert SM Dermatol Clin; 2011 Jan; 29(1):125-8. PubMed ID: 21095536 [TBL] [Abstract][Full Text] [Related]
38. [Progress in reaction identification and the clinical aspects of Hansen's neuritis]. Carayon A Acta Leprol; 1986; 4(2):237. PubMed ID: 3551461 [No Abstract] [Full Text] [Related]
39. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up. Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636 [TBL] [Abstract][Full Text] [Related]
40. Shall we continue with nerve trunk decompression in leprosy? Malaviya GN Indian J Lepr; 2004; 76(4):331-42. PubMed ID: 16119143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]